Kobo Biotech - Quaterly Results

08 Nov 2021 Evaluate
A minor change in the total revenue was seen in the September 2021 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended September 2021 is Rs. -18.64 millions as compared to Net Loss of Rs. -56.88 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 improved to -6.99% as compared to -6.67% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.17 0.36 -52.78 0.36 19.54 -98.16
PBIDT -6.99 -6.67 4.80 -9.45 -12.32 -23.30 -27.53 -6.53 321.59
Interest 1.35 36.00 -96.25 1.35 72.40 -98.14 108.41 144.75 -25.11
PBDT -8.34 -42.67 -80.45 -10.80 -84.72 -87.25 -135.94 -151.28 -10.14
Depreciation 10.30 14.21 -27.52 23.81 28.27 -15.78 56.37 58.78 -4.10
PBT -18.64 -56.88 -67.23 -34.61 -112.99 -69.37 -192.31 -210.06 -8.45
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -18.64 -56.88 -67.23 -34.61 -112.99 -69.37 -192.31 -210.06 -8.45
Equity 238.25 238.25 0.00 238.25 238.25 0.00 238.25 238.25 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kobo Biotech Share Price

3.90 -0.20 (-4.88%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.